• database DOAJ indexed

United Kingdom · Hindawi Limited

workspace_premium - — Medicine (miscellaneous) verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Contrast Media and Molecular Imaging

Contrast Media and Molecular Imaging is a journal indexed in SJR in Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging with an H index of 62. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1440 €. The scope of the journal is focused on molecular imaging, cellular imaging, contrast media, magnetic resonance imaging. It has a best quartile of -. It is published in English.

ISSN: 1555-4309

Publisher: Hindawi Limited

Category: Medicine (miscellaneous)

Indexation: verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0 -

H-index 62

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

23 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.440 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

DOAJ

SJR Impact

H-index

Docs (year)

Docs 3y

768

Total refs

Cites 3y

1023

Citable 3y

766

Cites/Doc 2y

1.27

Ref/Doc

8.67

Immediate OA

1440 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

CMR 2005: 1.05: Does dual-contrast MRI of the liver improve the detection of focal liver lesions? On-site results of a prospective multicenter study

Use of intra-articular carbon dioxide and air for MR arthrography: a feasibility study

CMR 2005: 3.04: Sentinel node imaging of breast cancer in mice using a dual-labeled nano-sized MRI-near-infrared optical hybrid contrast agent

CMR 2005: 3.03: New RGD peptide-based molecular imaging agents for detection of angiogenesis

CMR 2005: 3.02: The stromal mechanism: an inherent link between necrosis-avid contrast agents and photodynamic therapy

CMR 2005: 3.01: MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctylmannose conjugate (Gadofluorine M), a novel protein-avid contrast agent

CMR 2005: 2.06: Ferumoxtran-10 enhanced MR imaging in detection of metastases outside the normal surgical area in prostate cancer

CMR 2005: 2.05: Use of magnetic nanoparticles as intracellular agents for hyperthermia

CMR 2005: 2.04: MRI of cerebral ischemia with ultra-small superparamagnetic particles of iron oxide in mice

CMR 2005: 2.03: VSOP-C184 as contrast agent for MRI of atherosclerotic plaques: experimental results in rabbits

CMR 2005: 2.02: Interventional double-contrast MR angiography: intra-arterial injections of SPIO particles SHU 555 C (Resovist¬Æ) in combination with trueFISP imaging

CMR 2005: 2.01: High-field MRA with iron oxide blood-pool contrast agents: field strength effects on vascular contrast enhancement in rabbits at 1.5 and 3.0 T

SHOW MORE ARTICLES

CMR 2005: 1.06: Comparison of liver metastasis detectability from colorectal cancer between SPIO-MRI and diffusion-weighted imaging: how and when should SPIO-MRI be applied?

A hyperpolarized choline molecular probe for monitoring acetylcholine synthesis

CMR 2005: 1.04: Comparison of VSOP-C184, gadopentetate dimeglumine and ferucarbotran in T1-weighted dynamic and T2-weighted late MRI of focal liver lesions in rabbits

CMR 2005: 1.03: Analysis of hepatic uptake of anionic magnetic nanoparticles

CMR 2005: 1.02: Extraction rate of SPIO by the normal and gadolinium chloride-treated liver

CMR 2005: 1.01: The hepatobiliary excretion of Gd-BOPTA does not interfere with the clearance of other drugs

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

Brain Network Alterations in Alzheimer's Disease Identified by Early-Phase PIB-PET

Assessment of real-time myocardial uptake and enzymatic conversion of hyperpolarized [1-13C]pyruvate in pigs using slice selective magnetic resonance spectroscopy

Application of Image Processing Techniques in Molecular Imaging of Cancer

An imageable retinoid acid derivative to detect human cancer xenografts and study therapeutic dosing to reduce its toxicity

A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent

FAQs

SJR is not available (NPD) for Contrast Media and Molecular Imaging in the CountryOfPapers database.

Immediate OA APC is 1440 EUR.

The acceptance rate recorded for Contrast Media and Molecular Imaging is 30%.

Contrast Media and Molecular Imaging

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Contrast Media and Molecular Imaging?

What is the APC / publication cost?

What is the acceptance rate?